IHS Chemical Week

BP declines to comment on government opposition to potential takeover

BP declined to comment to CW on a report in The Telegraph that the UK government would oppose a potential takeover of the company. This follows speculation that there would be more consolidation in the energy sector after Shell announced that it would pay...

Uralkali approves share buyback program

The board of Uralkali (Berezniki, Russia) has approved a share buyback program, under which the company will purchase up to 468.75 million of its own shares—representing 15.97% of the company's equity capital—in the form of common shares and...

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com


Recipharm appoints new boss for Italian unit

Recipharm (Jordbro, Sweden), a contract development and manufacturing organization that produces pharmaceuticals and active pharmaceutical ingredients, has today announced the appointment of Giorgio Bruno as general manager of Recipharm Italia (Masate...


Sipchem Misses Earnings Estimates on Lower Revenues

The Saudi International Petrochemical Co. (Sipchem) reported third quarter net profit of SR84.1 million ($22.4 million), a 54% increase on the third quarter of 2009. The result was lower than consensus estimate of SR128 million and that of Sico Research...

Emerging Companies

Bayer MaterialScience taps BioAmber succinic acid for new range of biobased PU

Bayer Material Science (BMS) says it is introducing a range of waterborne, biobased polyurethane (PU) dispersions for textile applications using succinic acid supplied by BioAmber (Minneapolis). "With a renewable content that reaches as high as...


Sabic Reports Big Rise in Net Profit on Increased Sales and Higher Prices

Saudi Basic Industries (Sabic) reported a 46% rise in third quarter net profit to SR5.33 billion ($1.42 billion) compared with the same period in 2009. The net result was 6% higher than in the second quarter of this year. The company's gross income in the...


Teva offers to acquire Mylan for $40 billion

Teva Pharmaceutical Industries (PetaŠł• Tiqwa, Israel) has proposed to acquire Mylan in a transaction valued at $82.00/Mylan share, or a total of about $40 billion, with the consideration to comprise about 50% cash and 50% stock. The offer follows...


VCI calls for more 'factual discussion' over TTIP

Germany’s chemical industry trade association VCI (Frankfurt) has called for more objectivity and “an open discussion of the content” in the continuing discussions over the free trade agreement being negotiated between the European Union and...

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa